Transgenic pigs carrying both hHO-1 and hDAF transgenes for...

Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C800S014000, C424S093200

Reexamination Certificate

active

07378569

ABSTRACT:
The invention provides a transgenic animal carrying two transgenes, one encoding a human decay accelerating factor (hDAF) and the other encoding a human heme oxygenase-1 (hHO)-1, which are useful for providing cells, tissues or organs therefrom for xenotransplantation.

REFERENCES:
Cozzi et al., The generation of transgenic pigs as potential organ donors for human, 1995, Nature Medicine, 1:964-966.
Zhang et al., Animal models in xenotransplantation. Exp. Opin. Invest. Drugs, 2000, 9:2051-2068.
Logan et al., Potential use of genetically modified pigs as organ donors for transplantation into humans. Clin Exp Pharmacol Physiol. Dec. 1999;26(12):1020-5. Review.
Murphy, L.J and Silha, J.V., Unexpected and unexplained phenotypes in transgenic models. Growth Hormone and IGF Research, 10:233-235, 2000.
Sigmund. Viewpoint: are studies in genetically altered mice out of control?Arterioscler Thromb Vasc Biol. Jun. 2000;20(6):1425-9. Review.
Hammer et al.,Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. Nov. 30, 1990;63(5):1099-112.
Kappel, Regulating gene expression in transgenic animals. Current Biology, 3:548-553, 1992.
Williams and Wagner, Transgenic animals in integrative biology: approaches and interpretation. J. Appl. Physiol., 88:1119-1126, 2000.
Niemann, Transgenic farm animals get off the ground. 1997, Transg. Res. 7:73-75.
Nebert et al., How knockout mouse lines will be used to study the role of drug-metabolizing enzymes and their receptors during reproduction and development, in environmental toxicity, cancer, and oxidative stress. Biochem Pharmacol. Feb. 7, 1997;53(3):249-54. Review.
McCurry et al., Human complement regulatory proteins swine-to-primate cardiac xenografts from humoral injury.Nat Med. May 1995;1(5):423-7.
Yet SF aet al., Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. Jul. 20, 2001;89(2):168-173.
Cooper, “Is Xenotransplantation a realistic clinical option?”,Transplant. Proc., 1992: 24:2393-2396.
Nowak, “Xenotransplants set to resume”,Science, 1994: 266:1148-1151.
Cozzi, “Expression of human decay accelerating factor in transgenic pigs”,Transplant. Proc., 1994; 26:1402-1403.
McCurry, “Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury”,Nature Med., 1995; 1:423-427.
Fodor, “Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneica hyperacute organ rejection”,Proc. Natl. Acad. Sci., 1994; 91:11153-11157.
Schmoeckel, “Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts”,Transplantation, 1996; 62:729-734.
Byrne, “Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage”,Transplantation, 1997; 63:149-155.
Kroshus, “Expression of human CD59 in transgenic pig organs enhance organ survival in an ex vivo xenogeneic perfusion model”,Transplantation, 1997; 61: 1513-1521.
Storck, “Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood”,Transplantation, 1997; 63:304-310.
Pierson, “Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood”,J. Heart and Lung Trans., 1997; 16:231-239.
Diamond, “Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium”,Transplantation, 1996; 61:1241-1249.
Cozzi, “Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts”,Transplant. Proc., 2000; 70:15-21.
Vial, “Life supporting function for over one month of a transgenic porcine heart in a baboon”,J. Heart Lung Transplant, 2000; 19:224-229.
Galili, “The natural anti-gal antibody: evolution and autoimmunity in man”,Immunol. Ser.; 1991; 55:355-373.
Galili, “Man, apes, and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells”,J. Biol. Chem.; 1988; 263:17755-17762.
Larsen, “Isolation of a cDNA encoding a murine UDPgalactose:$\beta $-D-galactosyl-1,4-N-acetyl-D-glucosaminide $\alpha $-1,3-galactosyltransferase: expression cloning by gene transfer”,PNAS, 1989; 86:8227-8231.
Larsen, R., “Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UPD-Gal:β-D-Gal(1,4)-D-GlcNAc α(1,3)-galactosyltransferase cDNA”,J. Biol. Chem., 1990: 265:7055-7061.
Sandrin, M., “Characterization of cDNA clones for porcine α(1,3)galatosyl transferase: The enzyme generating the Galα(1,3)Gal epitope”,Xenotransplantation, 1994; 1:81-88.
Joziasse, D., “Characterization of an α1-3-Gaactosyltransferase Homologue on human chromosome 12 that is organized as a processed pseudogene”,J. Biol. Chem., 1991; 266:6991-6998.
Dai, Y., “Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs”,Nature Biotech., 2002; 20:251-255.
Lai, L., “Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning”,Science, 2002; 295:1089-1092.
Phelps, C., “Production of α-1,3-galactosyltransferase-deficient pigs”,Science, 2002; 299:411-414.
Sharma, A., “Reduction in the level of Gal($\alpha $1,3)Gal in transgenic mice and pigs by the expression of an $\alpha $(1,2)fucosyltransferase”,PNAS, 1996; 93:7190-7195.
Maines, M., “The heme oxygenase system: A regulator of second messenger gases”,Ann. Rev. Pharmacol. Toxicol., 1997; 37:517-554.
Choi, A., “Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury”,Am. Journ. Of Resp. Cell and Molecular. Biol., 1996; 15:9-19.
Poss, K., “Reduced stress defense in heme oxygenase 1-deficient cells”,Proc. Natl. Acad. Sci. of USA, 1997; 94:10925-10930.
Poss, K., “Heme oxygenase 1 is required for mammalian iron reutilization”,Proc. Natl. Acad. Sci. of USA, 1997; 94:10919-10924.
Soares, M., “Expression of heme oxygenase-1 can determine cardiac xenograft survival”,Nature Medicine, 1998; 4:1073-1077.
Yachie, A., “Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency”,J. of Clin. Invest., 1999; 103:129-135.
Sato, K., Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants,J. Immun., 2001; 166:4185-4194.
Pileggi, A., “Heme oxygenase-1 induction in islet cells result in protection from apoptosis and improved in vivo function after transplantation”,Diabetes; 2001; 50:1983-1991.
Otterbein, L., “Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury”,J. of Clin. Invest., 1999; 103:1047-1054.
Amersi, F., “Upregulation of heme oxygenase-1 protects genetically fat zucker rat livers from ischemia/reperfusion injury”,J. Clin. Invest., 1999; 104:1631-1639.
Shiraishi, F., “Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis”,Am. J. Physiol Renal Physiol., 2000; 278:F726-F736.
Minamino, T., “Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia”,PNAS, 2001; 98:8798-8803.
Yet, S., “Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice”,Cir. Res., 2001; 89:168-173.
Medof, M., “Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement”,Proc. Natl. Acad. Sc

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Transgenic pigs carrying both hHO-1 and hDAF transgenes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transgenic pigs carrying both hHO-1 and hDAF transgenes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic pigs carrying both hHO-1 and hDAF transgenes for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2815641

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.